Literature DB >> 33387460

Diverging consequences of hexosamine biosynthesis in cardiovascular disease.

Qinfeng Li1, Heinrich Taegtmeyer2, Zhao V Wang3.   

Abstract

Entities:  

Keywords:  Cardiac hypertrophy; Diabetes related cardiomyopathy; Heart failure; Hexosamine biosynthetic pathway; Metabolic remodeling; Myocardial infarction; O-GlcNAcylation; Pressure overload

Mesh：

Substances：

Year:  2020        PMID： 33387460      PMCID： PMC9444167          DOI： 10.1016/j.yjmcc.2020.12.016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.763


× No keyword cloud information.
  10 in total

1.  O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.

Authors:  Lewis J Watson; Heberty T Facundo; Gladys A Ngoh; Mohamed Ameen; Robert E Brainard; Kewakebt M Lemma; Bethany W Long; Sumanth D Prabhu; Yu-Ting Xuan; Steven P Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.

Authors:  Ying Hu; Darrell Belke; Jorge Suarez; Eric Swanson; Raymond Clark; Masahiko Hoshijima; Wolfgang H Dillmann
Journal:  Circ Res       Date:  2005-04-07       Impact factor: 17.367

3.  Hyperglycemia Acutely Increases Cytosolic Reactive Oxygen Species via O-linked GlcNAcylation and CaMKII Activation in Mouse Ventricular Myocytes.

Authors:  Shan Lu; Zhandi Liao; Xiyuan Lu; Dörthe M Katschinski; Mark Mercola; Ju Chen; Joan Heller Brown; Jeffery D Molkentin; Julie Bossuyt; Donald M Bers
Journal:  Circ Res       Date:  2020-03-05       Impact factor: 17.367

4.  O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure.

Authors:  Mariya Kronlage; Matthias Dewenter; Johannes Grosso; Thomas Fleming; Ulrike Oehl; Lorenz H Lehmann; Inês Falcão-Pires; Adelino F Leite-Moreira; Nadine Volk; Hermann-Josef Gröne; Oliver J Müller; Albert Sickmann; Hugo A Katus; Johannes Backs
Journal:  Circulation       Date:  2019-06-14       Impact factor: 29.690

Review 5.  Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.

Authors:  Victor M Darley-Usmar; Lauren E Ball; John C Chatham
Journal:  J Mol Cell Cardiol       Date:  2011-08-22       Impact factor: 5.000

6.  Cardioprotection by N-acetylglucosamine linkage to cellular proteins.

Authors:  Steven P Jones; Natasha E Zachara; Gladys A Ngoh; Bradford G Hill; Yasushi Teshima; Aruni Bhatnagar; Gerald W Hart; Eduardo Marbán
Journal:  Circulation       Date:  2008-02-19       Impact factor: 29.690

7.  Proposed regulation of gene expression by glucose in rodent heart.

Authors:  Martin E Young; Jie Yan; Peter Razeghi; Robert C Cooksey; Patrick H Guthrie; Stanislaw M Stepkowski; Donald A McClain; Rong Tian; Heinrich Taegtmeyer
Journal:  Gene Regul Syst Bio       Date:  2007-11-05

8.  Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.

Authors:  Shiraj Sen; Bijoy K Kundu; Henry Cheng-Ju Wu; S Shahrukh Hashmi; Patrick Guthrie; Landon W Locke; R Jack Roy; G Paul Matherne; Stuart S Berr; Matthew Terwelp; Brian Scott; Sylvia Carranza; O Howard Frazier; David K Glover; Wolfgang H Dillmann; Michael J Gambello; Mark L Entman; Heinrich Taegtmeyer
Journal:  J Am Heart Assoc       Date:  2013-05-17       Impact factor: 5.501

9.  AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Authors:  Roselle Gélinas; Florence Mailleux; Justine Dontaine; Laurent Bultot; Bénédicte Demeulder; Audrey Ginion; Evangelos P Daskalopoulos; Hrag Esfahani; Emilie Dubois-Deruy; Benjamin Lauzier; Chantal Gauthier; Aaron K Olson; Bertrand Bouchard; Christine Des Rosiers; Benoit Viollet; Kei Sakamoto; Jean-Luc Balligand; Jean-Louis Vanoverschelde; Christophe Beauloye; Sandrine Horman; Luc Bertrand
Journal:  Nat Commun       Date:  2018-01-25       Impact factor: 14.919

10.  Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling.

Authors:  Diem Hong Tran; Herman I May; Qinfeng Li; Xiang Luo; Jian Huang; Guangyu Zhang; Erica Niewold; Xiaoding Wang; Thomas G Gillette; Yingfeng Deng; Zhao V Wang
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919
  10 in total
  3 in total

Review 1.  Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19.

Authors:  Toshifumi Matsuyama; Steven K Yoshinaga; Kimitaka Shibue; Tak W Mak
Journal:  Cell Death Differ       Date:  2021-10-18       Impact factor: 15.828

2.  YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload.

Authors:  Toshihide Kashihara; Risa Mukai; Shin-Ichi Oka; Peiyong Zhai; Yasuki Nakada; Zhi Yang; Wataru Mizushima; Tsutomu Nakahara; Junco S Warren; Maha Abdellatif; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

3.  PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart.

Authors:  Qinfeng Li; Chao Li; Abdallah Elnwasany; Gaurav Sharma; Yu A An; Guangyu Zhang; Waleed M Elhelaly; Jun Lin; Yingchao Gong; Guihao Chen; Meihui Wang; Shangang Zhao; Chongshan Dai; Charles D Smart; Juan Liu; Xiang Luo; Yingfeng Deng; Lin Tan; Shuang-Jie Lv; Shawn M Davidson; Jason W Locasale; Philip L Lorenzi; Craig R Malloy; Thomas G Gillette; Matthew G Vander Heiden; Philipp E Scherer; Luke I Szweda; Guosheng Fu; Zhao V Wang
Journal:  Circulation       Date:  2021-06-09       Impact factor: 39.918
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.